n(g),n(g')-dimethyl-l-arginine has been researched along with Blood Clot in 10 studies
N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine
| Excerpt | Relevance | Reference |
|---|---|---|
| "LAA thrombus was detected in 27 subjects by transesophageal echocardiography." | 5.42 | Asymmetric dimethylarginine predicts left atrial appendage thrombus in patients with non-valvular atrial fibrillation. ( Chi, Y; Duan, T; Rong, Y; Shao, Y; Wang, Y; Xia, W, 2015) |
| "In the present study, we tested whether a novel genetic variant in dimethylarginine dimethylaminohydrolase 1 (DDAH1), an important ADMA hydrolyzing gene, was associated with stroke and coronary heart disease (CHD) susceptibility in the Chinese Han population." | 3.76 | A novel loss-of-function DDAH1 promoter polymorphism is associated with increased susceptibility to thrombosis stroke and coronary heart disease. ( Ding, H; Hui, R; Lu, Z; Shaffer, JR; Wang, DW; Wang, H; Wang, X; Wu, B; Yan, J, 2010) |
| "LAA thrombus was detected in 27 subjects by transesophageal echocardiography." | 1.42 | Asymmetric dimethylarginine predicts left atrial appendage thrombus in patients with non-valvular atrial fibrillation. ( Chi, Y; Duan, T; Rong, Y; Shao, Y; Wang, Y; Xia, W, 2015) |
| "Immunosuppressants enhance thrombus formation in vivo." | 1.38 | Immunosuppressants accelerate microvascular thrombus formation in vivo: role of endothelial cell activation. ( Katzfuss, J; Klar, E; Lindenblatt, N; Püschel, A; Vollmar, B, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 8 (80.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stanisavljevic, N | 1 |
| Stojanovich, L | 1 |
| Djokovic, A | 1 |
| Todic, B | 1 |
| Dopsaj, V | 1 |
| Saponjski, J | 1 |
| Saponjski, D | 1 |
| Markovic, O | 1 |
| Belizna, C | 1 |
| Zdravkovic, M | 1 |
| Marisavljevic, D | 1 |
| Pang, P | 1 |
| Abbott, M | 1 |
| Abdi, M | 1 |
| Fucci, QA | 1 |
| Chauhan, N | 1 |
| Mistri, M | 1 |
| Proctor, B | 1 |
| Chin, M | 1 |
| Wang, B | 1 |
| Yin, W | 1 |
| Lu, TS | 1 |
| Halim, A | 1 |
| Lim, K | 1 |
| Handy, DE | 1 |
| Loscalzo, J | 1 |
| Siedlecki, AM | 1 |
| Xia, W | 1 |
| Wang, Y | 1 |
| Duan, T | 1 |
| Rong, Y | 1 |
| Chi, Y | 1 |
| Shao, Y | 1 |
| Mayer-Pickel, K | 1 |
| Kolovetsiou-Kreiner, V | 1 |
| Mörtl, MG | 1 |
| Schlembach, D | 1 |
| Eberhard, K | 1 |
| Obermayer-Pietsch, B | 1 |
| Lang, U | 1 |
| Cervar-Zivkovic, M | 1 |
| Lao, MC | 1 |
| Liu, LJ | 1 |
| Luo, CF | 1 |
| Lu, GH | 1 |
| Zhai, YS | 1 |
| Chen, XL | 1 |
| Gao, XR | 1 |
| Ding, H | 1 |
| Wu, B | 1 |
| Wang, H | 1 |
| Lu, Z | 1 |
| Yan, J | 1 |
| Wang, X | 1 |
| Shaffer, JR | 1 |
| Hui, R | 1 |
| Wang, DW | 1 |
| Sharma, P | 1 |
| Bentley, P | 1 |
| Püschel, A | 1 |
| Lindenblatt, N | 1 |
| Katzfuss, J | 1 |
| Vollmar, B | 1 |
| Klar, E | 1 |
| Lim, HS | 1 |
| Willoughby, SR | 1 |
| Schultz, C | 1 |
| Gan, C | 1 |
| Alasady, M | 1 |
| Lau, DH | 1 |
| Leong, DP | 1 |
| Brooks, AG | 1 |
| Young, GD | 1 |
| Kistler, PM | 1 |
| Kalman, JM | 1 |
| Worthley, MI | 1 |
| Sanders, P | 1 |
| Schnabel, R | 1 |
| Blankenberg, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Correlation Of CoAGulation Biomarkers and Atrial Fibrillation Burden in Patients Post Catheter Ablation: the COAG-AF Pilot Study[NCT04947657] | 20 participants (Anticipated) | Observational | 2021-09-22 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
10 other studies available for n(g),n(g')-dimethyl-l-arginine and Blood Clot
| Article | Year |
|---|---|
Asymmetric Dimethylarginine Is a Marker of Endothelial Dysfunction in Thrombotic Antiphospholipid Syndrome Patients.
Topics: Antiphospholipid Syndrome; Arginine; Biomarkers; C-Reactive Protein; Dilatation, Pathologic; Endothe | 2022 |
Pre-clinical model of severe glutathione peroxidase-3 deficiency and chronic kidney disease results in coronary artery thrombosis and depressed left ventricular function.
Topics: Animals; Arginine; Disease Models, Animal; Glutathione Peroxidase; Heart Diseases; Mice; Mice, Knock | 2018 |
Asymmetric dimethylarginine predicts left atrial appendage thrombus in patients with non-valvular atrial fibrillation.
Topics: Aged; Arginine; Atrial Appendage; Atrial Fibrillation; Female; Humans; Male; Middle Aged; Nitric Oxi | 2015 |
Endothelin 1, ADMA and SDMA in pregnancies with obstetric and thrombotic antiphospholipid syndrome.
Topics: Adult; Antiphospholipid Syndrome; Arginine; Chronic Disease; Endothelin-1; Endothelium, Vascular; Fe | 2016 |
[Effect of asymmetrical dimethylarginine for predicting pro-thrombotic risk in atrial fibrillation].
Topics: Arginine; Atrial Fibrillation; Cardiovascular Diseases; Heart Atria; Humans; Stereoisomerism; Thromb | 2016 |
A novel loss-of-function DDAH1 promoter polymorphism is associated with increased susceptibility to thrombosis stroke and coronary heart disease.
Topics: Aged; Amidohydrolases; Arginine; Asian People; Binding Sites; Biomarkers; Case-Control Studies; Cell | 2010 |
Down but not out: candidate gene-based studies still have value in a world dominated by whole genome approaches.
Topics: Amidohydrolases; Arginine; Asian People; Biomarkers; China; Coronary Artery Disease; Evidence-Based | 2010 |
Immunosuppressants accelerate microvascular thrombus formation in vivo: role of endothelial cell activation.
Topics: Animals; Arginine; Endothelium, Vascular; Immunohistochemistry; Immunosuppressive Agents; Male; Mice | 2012 |
Effect of atrial fibrillation on atrial thrombogenesis in humans: impact of rate and rhythm.
Topics: Aged; Antithrombin III; Arginine; Atrial Fibrillation; Catheter Ablation; CD40 Ligand; Enzyme Inhibi | 2013 |
Oxidative stress in cardiovascular disease: successful translation from bench to bedside?
Topics: Arginine; Atherosclerosis; Biomarkers; Cardiovascular Diseases; Endothelium, Vascular; Hemorheology; | 2007 |